9 employees
Primmune Therapeutics is a Biotechnology company.
2017
$27M
from 4 investors over 4 rounds
Primmune Therapeutics raised $4M on January 12, 2021
Investors: Bioqube Ventures
Primmune Therapeutics raised $27M on October 27, 2020
Investors: Samsara BioCapital, Oberland Capital and Polaris Partners